Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review
Crossref DOI link: https://doi.org/10.1007/s00259-017-3895-x
Published Online: 2017-12-16
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
von Eyben, Finn Edler http://orcid.org/0000-0001-8763-007X
Roviello, Giandomenico
Kiljunen, Timo
Uprimny, Christian
Virgolini, Irene
Kairemo, Kalevi
Joensuu, Timo
License valid from 2017-12-16